Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03799601
Brief Title: Docetaxel Combined With Carboplatin Plus Anlotinib as First Line Treatment in NSCLC (ALTER-L013)

First Submitted : January 8, 2019
First Submitted that Met QC Criteria : January 8, 2019
First Posted : January 10, 2019

Last Update Submitted that Met QC Criteria : January 8, 2019
Last Update Posted : January 10, 2019